Use of reperfusion therapy and time delay in patients with ischaemic stroke by immigration status: A register‐based cohort study in Denmark
GF Mkoma, M Norredam, HK Iversen… - European Journal of …, 2022 - Wiley Online Library
Background and purpose Reperfusion therapy is the mainstay of treatment for acute
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
Use of reperfusion therapy and time delay in patients with ischaemic stroke by immigration status: A register‐based cohort study in Denmark.
GF Mkoma, M Norredam, HK Iversen… - European Journal …, 2022 - search.ebscohost.com
Background and purpose: Reperfusion therapy is the mainstay of treatment for acute
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
Use of reperfusion therapy and time delay in patients with ischaemic stroke by immigration status: A register-based cohort study in Denmark
GF Mkoma, M Norredam, HK Iversen… - European journal …, 2022 - pubmed.ncbi.nlm.nih.gov
Background and purpose Reperfusion therapy is the mainstay of treatment for acute
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
[PDF][PDF] Use of reperfusion therapy and time delay in patients with ischaemic stroke by immigration status: A register-based cohort study in Denmark
GF Mkoma, M Norredam, HK Iversen, G Andersen… - 2022 - core.ac.uk
Background and purpose: Reperfusion therapy is the mainstay of treatment for acute
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
[PDF][PDF] Use of reperfusion therapy and time delay in patients with ischaemic stroke by immigration status: A register-based cohort study in Denmark
GF Mkoma, M Norredam, HK Iversen, G Andersen… - 2022 - researchgate.net
Background and purpose: Reperfusion therapy is the mainstay of treatment for acute
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
[HTML][HTML] Use of reperfusion therapy and time delay in patients with ischaemic stroke by immigration status: A register‐based cohort study in Denmark
GF Mkoma, M Norredam, HK Iversen… - European Journal of …, 2022 - ncbi.nlm.nih.gov
Background and purpose Reperfusion therapy is the mainstay of treatment for acute
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
Use of reperfusion therapy and time delay in patients with ischaemic stroke by immigration status: A register-based cohort study in Denmark
GF Mkoma, M Norredam, HK Iversen… - European Journal of …, 2022 - pure.au.dk
Background and purpose: Reperfusion therapy is the mainstay of treatment for acute
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
Use of reperfusion therapy and time delay in patients with ischaemic stroke by immigration status: A register-based cohort study in Denmark
GF Mkoma, M Norredam, HK Iversen… - European Journal of …, 2022 - research.regionh.dk
BACKGROUND AND PURPOSE: Reperfusion therapy is the mainstay of treatment for acute
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
[引用][C] Use of reperfusion therapy and time delay in patients with ischaemic stroke by immigration status: A register-based cohort study in Denmark
GF Mkoma, ML Nørredam, HK Iversen - mesu.ku.dk
Background and purpose Reperfusion therapy is the mainstay of treatment for acute
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
Use of reperfusion therapy and time delay in patients with ischaemic stroke by immigration status: a register-based cohort study in Denmark
GF Mkoma, M Norredam, HK Iversen… - European Journal of …, 2022 - vbn.aau.dk
Background and purpose: Reperfusion therapy is the mainstay of treatment for acute
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …
ischaemic stroke (AIS); however, little is known about the use of reperfusion therapy and …